Neuro-oncology: new hope for patients with gliomas Journal Article
| Author: | Deangelis, L. M. |
| Article Title: | Neuro-oncology: new hope for patients with gliomas |
| Keywords: | cancer survival; unclassified drug; gene mutation; overall survival; mutation; clinical trial; cancer recurrence; bevacizumab; drug efficacy; temozolomide; follow up; glioma; brain neoplasms; progression free survival; controlled clinical trial; randomized controlled trial; astrocyte; enzyme activity; irinotecan; glioma cell; glioblastoma; cognition; oligodendroglioma; cognitive rehabilitation; tumor growth; cognition disorders; hypoxia inducible factor 1alpha; astrocytoma; arginine; isocitrate dehydrogenase; isocitrate dehydrogenase 1; oligodendroglia |
| Journal Title: | Lancet Neurology |
| Volume: | 9 |
| Issue: | 1 |
| ISSN: | 1474-4422 |
| Publisher: | Elsevier Science, Inc. |
| Date Published: | 2010-01-01 |
| Start Page: | 17 |
| End Page: | 18 |
| Language: | English |
| DOI: | 10.1016/s1474-4422(09)70326-6 |
| PUBMED: | 20083029 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Cited By (since 1996): 1" - "Export Date: 20 April 2011" - "CODEN: LNAEA" - "Source: Scopus" |
